Sensitive ASX Announcement

Dose Escalation Approved in ACCENT Clinical Trial of AMP945

Published: 11/04/23, 12:17pm (AEST)2 pages
Amplia Therapeutics Limited
ATX:ASXHealthcare

Recent ATX Announcements

Price Sensitive only